L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling

Chengsha Yuan, Changpeng� Hu, Huyue Zhou, Wuyi Liu, Wenjing Lai, Ya‐Feng Liu, Yue Yin, Guobing� Li, Rong ZhangNeoplasia 2025 · DOI

Abstract

This work demonstrates that L-methionine promotes CD8<sup>+</sup> T cell-mediated killing of hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling. Our study introduces a novel and convenient approach to inhibit PCSK9 and provides a theoretical basis for the rational supplementation of L-methionine in liver cancer patients.
BibTeX
@inproceedings{yuan2025l,
  author = {Chengsha Yuan and Changpeng� Hu and Huyue Zhou and Wuyi Liu and Wenjing Lai and Ya‐Feng Liu and Yue Yin and Guobing� Li and Rong Zhang},
  title = {{L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling}},
  booktitle = {Neoplasia},
  year = {2025},
  doi = {10.1016/j.neo.2025.101160},
}

Loading related content...

Figure